Back
Sage Therapeutics Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
34
SAGE
Sage Therapeutics
Last Price:
5.74
Seasonality Move:
13.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Sage Therapeutics Price Quote
$5.74
-0.57 (-9.03%)
(Updated: November 12, 2024 at 5:55 PM ET)
Sage Therapeutics Key Stats
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Day range:
$6.29 - $6.65
52-week range:
$5.64 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.58
P/B ratio:
0.7%
Volume:
517.4K
Avg. volume:
720.5K
1-year change:
-63.1%
Market cap:
$386M
Revenue:
$86.5M
EPS:
$-5.57
How Much Does Sage Therapeutics Make?
-
How Much Are Sage Therapeutics's Sales Annually?
SAGE Revenues are $86.5M -
How Much Profit Does Sage Therapeutics's Make A Year?
SAGE net income is -$541.5M
Is Sage Therapeutics Growing As A Company?
-
What Is Sage Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 3.37% -
What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sage Therapeutics Stock Price Performance
-
Did Sage Therapeutics Stock Go Up Last Month?
Sage Therapeutics share price went down by -4.25% last month -
Did SAGE's Share Price Rise Over The Last Year?
SAGE share price fell by -63.1% over the past 1 year
What Is Sage Therapeutics 52-Week High & Low?
-
What Is Sage Therapeutics’s 52-Week High Share Price?
Sage Therapeutics has traded as high as $28.26 over the past 52 weeks -
What Is Sage Therapeutics’s 52-Week Low Share Price?
Sage Therapeutics has traded as low as $5.64 over the past 52 weeks
Sage Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sage Therapeutics?
-
How Much Debt Does Sage Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sage Therapeutics Have?
Cash and short term investments quarterly total is $569.2M -
What Is Sage Therapeutics’s Book Value Per Share?
Book value per share is 9.02
Is Sage Therapeutics Cash Flow Positive?
-
What Is SAGE Cash Flow From Operations?
Cash flow from operations (TTM) is -$320.2M -
What Is Sage Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.4M -
What Is Sage Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $262.2M
Sage Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SAGE return on invested capital is -48.2% -
What Is Sage Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -43.07% -
What Is SAGE Return On Equity?
ROE is a measure of profitability and is -48.2%
Sage Therapeutics Earnings Date & Stock Price
-
What Is Sage Therapeutics's Stock Price Today?
A single share of SAGE can be purchased today for 6.31 -
What Is Sage Therapeutics’s Stock Symbol?
Sage Therapeutics trades on the nasdaq under the ticker symbol: SAGE -
When Is Sage Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sage Therapeutics is scheduled on February 14, 2025 -
When Is SAGE's next ex-dividend date?
Sage Therapeutics's next ex-dividend date is November 13, 2024 -
How To Buy Sage Therapeutics Stock?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sage Therapeutics Competitors
-
Who Are Sage Therapeutics's Competitors?
Below is a list of companies who compete with Sage Therapeutics or are related in some way:
Sage Therapeutics Dividend Yield
-
What Is SAGE Dividend Yield?
Sage Therapeutics’s dividend yield currently is 0% -
What Is Sage Therapeutics’s Payout Ratio?
Sage Therapeutics’s payout ratio is 0% -
When Did Sage Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Sage Therapeutics’s Dividend Per Share?
Sage Therapeutics pays a dividend of $0.00 per share
Sage Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 1.32% |
| Revenue: | 337.08% | 9.37% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 16 |
| Sell Recommendations: | 0 |
| Price Target: | 10.00 |
| Upside from Last Price: | 58.48% |